Liaoning Boao Bio-pharmaceutical Co., Ltd. ibhizimusi remazuva ano biopharmaceutical rinobatanidza R&D uye kugadzirwa kwe insulin yakatevedzana zvigadzirwa.Inofukidza nzvimbo ye35,000 square metres uye nzvimbo yekuvaka ye20,000 square metres.Izvo zviripo zvakagadziriswa zvinhu zvinoda kusvika 200 miriyoni RMB.Zvigadzirwa zvekambani iyi zvinonyanya kutungamira pasi rose genetic recombinant protein drug recombinant human insulin, uye maanalogi ayo anogara kwenguva refu ane insulin glargine, uye anokurumidza kuita analog insulin aspart.Iyi purojekiti yakavakwa muna 2020, iyo yakagadziridzwa yekuchenesa nhanho ndeyeABC, uye huru yekugadzira michina zvese zvinotengeswa kubva kuGermany.Nzvimbo yekuchenesa i6,300 square metres.Iyo purojekiti inoshandisa zvekumba zvekutanga-kirasi zvekuvaka uye tekinoroji yekuvaka, musangano wese unoshandisa BIM yemazuva ano kuenzanisira uye kutungamira kuvaka, dhigirii repamusoro rekutonga otomatiki uye dhizaini yehungwaru yemusangano wese.